ATE288254T1 - Methode zur behandlung von schlaganfall - Google Patents

Methode zur behandlung von schlaganfall

Info

Publication number
ATE288254T1
ATE288254T1 AT01979231T AT01979231T ATE288254T1 AT E288254 T1 ATE288254 T1 AT E288254T1 AT 01979231 T AT01979231 T AT 01979231T AT 01979231 T AT01979231 T AT 01979231T AT E288254 T1 ATE288254 T1 AT E288254T1
Authority
AT
Austria
Prior art keywords
treating stroke
patient
stroke
treating
administering
Prior art date
Application number
AT01979231T
Other languages
English (en)
Inventor
James Allen Clemens
David Lodge
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE288254T1 publication Critical patent/ATE288254T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processing Of Stones Or Stones Resemblance Materials (AREA)
  • Liquid Crystal Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
AT01979231T 2000-10-13 2001-09-28 Methode zur behandlung von schlaganfall ATE288254T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24042200P 2000-10-13 2000-10-13
PCT/US2001/027738 WO2002032389A1 (en) 2000-10-13 2001-09-28 Method of treating stroke

Publications (1)

Publication Number Publication Date
ATE288254T1 true ATE288254T1 (de) 2005-02-15

Family

ID=22906451

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01979231T ATE288254T1 (de) 2000-10-13 2001-09-28 Methode zur behandlung von schlaganfall

Country Status (8)

Country Link
EP (1) EP1330233B1 (de)
JP (1) JP2004511507A (de)
AT (1) ATE288254T1 (de)
AU (1) AU2002211217A1 (de)
CA (1) CA2420994A1 (de)
DE (1) DE60108775T8 (de)
ES (1) ES2236321T3 (de)
WO (1) WO2002032389A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1745170A (zh) 2002-12-17 2006-03-08 米迪缪尼疫苗股份有限公司 生物活性材料的高压喷雾干燥
KR20060094421A (ko) * 2005-02-24 2006-08-29 고재영 신규한 뇌졸중 치료제 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20000944A1 (es) * 1998-07-31 2000-09-20 Lilly Co Eli Derivados de sulfonamida

Also Published As

Publication number Publication date
EP1330233B1 (de) 2005-02-02
DE60108775T2 (de) 2006-01-12
WO2002032389A1 (en) 2002-04-25
DE60108775D1 (de) 2005-03-10
DE60108775T8 (de) 2006-08-24
EP1330233A1 (de) 2003-07-30
ES2236321T3 (es) 2005-07-16
CA2420994A1 (en) 2002-04-25
JP2004511507A (ja) 2004-04-15
AU2002211217A1 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
CY1109242T1 (el) Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου
ATE343388T1 (de) Pde-v hemmer zur behandlung von morbus parkinson
RU2010144637A (ru) Замещенные гамма-лактамы в качестве терапевтических агентов
ATE399782T1 (de) Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
ATE355374T1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE468137T1 (de) Inhibitoren von hmgb1 zur behandlung von gewebekrankheiten
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
DE60142037D1 (de) Nasale verabreichung von metoclopramid zur behandlung der gastroparese
SE0004101D0 (sv) New use
DE60130030D1 (de) Verfahren zur behandlung von glaukom
ATE288254T1 (de) Methode zur behandlung von schlaganfall
SE0004827D0 (sv) Therapeutic compounds
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
DE60229047D1 (de) Einzeldosis aromatase hemmer zur behandlung von unfruchtbarkeit
DE60330233D1 (de) Arsentherapie zur behandlung von autoimmunerkrankungen
ATE350034T1 (de) Verwendung von epothilone zur behandlung hyperparathyreoidismus
DE60236894D1 (de) Behandlung von statin-nebenwirkungen mit uridinderivaten
DE60003921D1 (de) Diphenyl-1,2,3-thiadiazol-3-oxide, zusammensetzungen und verfahren zur anwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties